2019 research updates on mds and aml from eha and asco
Published 2 years ago • 45 plays • Length 54:20Download video MP4
Download video MP3
Similar videos
-
49:01
a patients perspective on mds and aml: updates from eha asco
-
2:04
eha and asco 2023 highlights: promising treatments in aml, mds, and all
-
1:04:46
ash 2019 the latest in mds and secondary aml
-
3:49
excerpt: updates from ash 2019: the latest in mds and secondary aml 4/2/20
-
6:37
low-risk mds updates from ash19
-
59:51
updates from eha and asco 2021
-
57:07
higher-risk mds and newly diagnosed aml: what are the latest developments from eha 2022?
-
35:52
mid-year updates in aml research | dr. daver eha 2022 with q&a #aml
-
1:29
alice mims | asco 2018 | what are the current challenges facing aml treatment?
-
0:48
what is the cause of mds? #aml
-
9:42
germline pre-disposition to myeloid malignancies
-
3:02
highlights in aml and mds from eha 2022
-
0:59
dr. mesa on racial disparities in mpn, mds, and aml clinical trials
-
58:22
myelodysplastic syndromes: key take-home messages from eha and asco 2024
-
7:43
understanding the recent who mds classification updates
-
1:51
factors driving the transformation of chip to mds
-
1:05:39
post asco/eha 2023 roundtable discussion on the latest updates in mds
-
1:27
what’s the connection between myelodysplastic syndrome (mds) and aml-mrc?
-
4:03
understanding myelodysplastic syndrome’s nature as cancer